Pharmacogenomics of medications given via nonconventional administration routes: a scoping review - Supplementary Information

Table S1: Characteristics of included pharmacogenomics studies involving intramuscular administration routes Table S2: Outcomes and results of included pharmacogenomics studies on intramuscular administration routes Table S3: Characteristics of included pharmacogenomic studies on intrathecal/intraventricular administration routes Table S4: Outcomes and results of included pharmacogenomics studies on intrathecal/intraventricular administration routes Table S5: Characteristics of included pharmacogenomics studies on intrahepatic arterial, intratympanic, and subcutaneous administration routes Table S6: Outcomes and results of included pharmacogenomics studies on intrahepatic arterial, intratympanic, and subcutaneous administration routes Table S7: Characteristics of included pharmacogenomics studies on topical/intralesional and transdermal administration routes Table S8: Outcomes and results of included pharmacogenomics studies on topical/intralesional administration routes Table S9: Outcomes and results of included pharmacogenomics studies on transdermal administration routes Table S10: Recommendations for Medications Given via a Non-Conventional Administration Route Provided by Pharmacogenomic Associations